Zions Bancorporation, National Association (ZION) Earnings Analysis

Zions Bancorporation, National Association (ZION) next reports earnings on 2026-10-19, consensus EPS 1.63 USD. Last quarter (2026-07-20) it beat with EPS 3.05 USD vs 1.57 USD est (+94.3%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 8.90.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ZION next report earnings?

Next earnings date2026-10-19
Consensus EPS estimate1.63 USD
Revenue estimate0.89B

ZION earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-203.05 USD1.57 USD+94.3%Beat
2026-04-201.56 USD1.42 USD+9.9%Beat
2026-01-201.75 USD1.57 USD+11.5%Beat
2025-10-201.54 USD1.46 USD+5.5%Beat
2025-07-211.58 USD1.31 USD+20.6%Beat
2025-04-211.24 USD1.19 USD+4.2%Beat
2025-01-211.34 USD1.25 USD+7.2%Beat
2024-10-211.37 USD1.17 USD+17.1%Beat

Beat rate: 8/8 (100%) over reported quarters with consensus data.

ZION valuation and analyst view

Trailing P/E8.90
Trailing EPS8.014 USD
Price / book1.33
Dividend yield2.57%
Market cap10.30B
Analyst consensusHold (18 buy / 30 hold / 3 sell)
Avg price target76.6 USD

Related research pages

Frequently asked questions

When is Zions Bancorporation, National Association (ZION)'s next earnings date?

Zions Bancorporation, National Association is next scheduled to report on 2026-10-19, with a consensus EPS estimate of 1.63 USD and revenue estimate of 0.89B.

Did ZION beat earnings last quarter?

In its 2026-07-20 report, ZION posted EPS of 3.05 USD versus a 1.57 USD estimate — a beat of 94.3%.

What is ZION's earnings track record?

Over the last 8 reported quarters with consensus data, ZION beat estimates 8 times (100%).

What is ZION's current P/E ratio and EPS?

ZION trades at a trailing P/E of 8.90 on trailing EPS of 8.014125666418007 USD.

What do analysts rate ZION?

Analyst consensus is "Hold" across 51 ratings (0 strong buy, 18 buy, 30 hold, 3 sell, 0 strong sell). Average 12-month price target: 76.6 USD.